Skip to main content
OpenTrials
Completed

NCT Number: NCT04642534

Circadian Clocks and Eating Patterns (Cohort)

For women of reproductive age, the overall postpartum weight retention (weight gain between pregnancies) plays a significant role in long-term obesity. With 20% of women retaining ≥ 5 kg at 12 months postpartum, the risk of developing conditions, such as gestational diabetes mellitus (GDM), metabolic syndrome (MS) and subsequently diabetes and cardiovascular diseases, is substantially increased. In post-GDM mothers (women who had GDM in their recent pregnancy), postpartum weight retention is also an essential predictor of future diabetes.

Recent studies have identified the impact of circadian rhythms (influencing sleep/wake cycles) and diurnal rhythm of eating (when and how often calories are consumed over a 24h period) on cardio-metabolic disorders. In women, one remarkable feature of the postpartum period is an 'externally imposed' circadian misalignment of both sleep and eating rhythms, because most babies take several weeks to months to establish their daily pattern of activity and feeding, which is particularly relevant for breastfeeding women, as the responsibility is generally on the mother.

The overarching goal of this project is to explore the interplay between the diurnal rhythm of eating, circadian and metabolic parameters in humans. The potential postpartum effects of circadian disruption will be unraveled in women who had GDM during their pregnancy and those with an uneventful pregnancy. These women are subject to a circadian misalignment due to their 'externally imposed' changes in sleep/wake cycles and eating times in the postpartum period.

With a comprehensive approach combining molecular characterization of in vivo and in vitro circadian clock parameters along with metabolic, endocrine, transcriptomic, and lipidomic studies, the investigators will assess if eating duration and/or circadian misalignment impact on circadian clock parameters of postpartum women in a prospective cohort of 6 months.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 18-40 years
  • Breastfeeding mothers at 4-8 week postpartum
  • With or without gestational diabetes mellitus diagnosed at 24-32 gestational weeks, according to the International Association of Diabetes and Pregnancy Study Groups (IADPSG) consensus criteria
  • Confident use of a smartphone and able to take regular pictures of food/drinks

Exclusion criteria

  • Pre-existing diabetes (prior to pregnancy)
  • Major illness/fever over the 2 weeks (prior to the visits with blood tests)
  • Shift work or work at irregular hours planned after maternity leave
  • Active cancer and/or oncologic treatment over the previous 12 months
  • Coagulation disorder, on regular anticoagulant drug, skin disorder affecting wound healing
  • Enrolled in a clinical trial / intervention study
  • Major known mental illness, unable to give informed consent
  • Inability to follow the study procedures

Treatment and study plan

Primary outcomes

  1. Eating duration

    Time frame: Changes between baseline and the close-out visit (i.e. changes between Month 0 and Month 6)

    Duration from the first to last caloric intake over 24-hour cycle

  2. Correlation of in vitro circadian parameters (amplitude and magnitude) with clinical metabolic health outcomes (body weight)

    Time frame: At baseline

    Measured in cultured skin fibroblasts

Secondary outcomes

  1. Sleep/wake cycles

    Time frame: Changes between baseline and the close-out visit (i.e. changes between Month 0 and Month 6)

    Measured by actigraphy

  2. Sleep/wake cycles

    Time frame: Changes between baseline and the close-out visit (i.e. changes between Month 0 and Month 6)

    Measured by the Pittsburgh Sleep Quality Index (scale 0-21, 0 indicating no sleeping difficulty, 21 indicating severe sleeping difficulties)

  3. Body weight

    Time frame: Changes between baseline and the close-out visit (i.e. changes between Month 0 and Month 6)

    Measured by bioelectrical impedance analysis

  4. Fat mass

    Time frame: Changes between baseline and the close-out visit (i.e.changes between Month 0 and Month 6)

    Measured by bioelectrical impedance analysis

  5. Fat-free mass

    Time frame: Changes between baseline and the close-out visit (i.e. changes between Month 0 and Month 6)

    Measured by bioelectrical impedance analysis

  6. Physical activity (activity count per minute)

    Time frame: Changes between baseline and the close-out visit (i.e. changes between Month 0 and Month 6)

    Measured by actigraphy

  7. Fasting glucose

    Time frame: Changes between baseline and the close-out visit (i.e. changes between Month 0 and Month 6)

    Measured by clinical chemistry

  8. Lipid profile (concentration of total cholesterol, LDL cholesterol, triglycerides, HDL cholesterol)

    Time frame: Changes between baseline and the close-out visit (i.e. changes between Month 0 and Month 6)

    Measured by clinical chemistry

  9. Glucose excursion (time-in-range, coefficient of variation)

    Time frame: Changes between baseline and the close-out visit (i.e. changes between Month 0 and Month 6)

    Measured by continuous glucose monitoring

Other outcomes

  1. Blood hormonal profile

    Time frame: Changes between baseline and the close-out visit (i.e. changes between Month 0 and Month 6)

    Insulin and thyroid-stimulating hormone (mIU/L)

  2. Blood hormonal profile

    Time frame: Changes between baseline and the close-out visit (i.e. changes between Month 0 and Month 6)

    Cortisol (nmol/L)

  3. Markers of lipid metabolism

    Time frame: Changes between baseline and the close-out visit (i.e. changes between Month 0 and Month 6)

    Measured by high-throughput mass spectrometry lipidomics

  4. Metabolomic parameters of energy metabolism

    Time frame: Changes between baseline and the close-out visit (i.e. changes between Month 0 and Month 6)

    Measured by high-throughput mass spectrometry metabolomics

Sponsors and collaborators

Lead sponsor

University of Lausanne Hospitals

Other

Registry information

Official study title

Molecular and Functional Interplay Between the Circadian Clocks and Eating Patterns in Patients With Cardio-metabolic Diseases (Cohort)

Important dates

Study start
2020
Primary completion
2022
Study completion
2022
First posted
Nov 24, 2020
Registry last updated
Dec 11, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.